Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians

…, LP Boulet, MM Cloutier, R Fuller, PM Gold, V Hoffstein… - Chest, 1998 - journal.chestnet.org
1. Cough can (a) be an important defense mechanism to help clear excessive secretions
and foreign material from airways;(b) be an important factor in the spread of infection;(c) …

[HTML][HTML] Review of oral appliances for treatment of sleep-disordered breathing

V Hoffstein - Sleep and Breathing, 2007 - Springer
Between 1982 and 2006, there were 89 distinct publications dealing with oral appliance
therapy involving a total of 3,027 patients, which reported results of sleep studies performed …

Evaluation of the upper airway in patients with obstructive sleep apnea

…, WB Gefter, C Guilleminault, EA Hoffman, V Hoffstein… - Sleep, 1991 - academic.oup.com
Multiple methods have been used to study the structure and physiological behavior of the
upper airway (UA) in patients with obstructive sleep apnea (OSA). Valuable information may …

NTRU: A ring-based public key cryptosystem

J Hoffstein, J Pipher, JH Silverman - International algorithmic number …, 1998 - Springer
We describe NTRU, a new public key cryptosystem. NTRU features reasonably short, easily
created keys, high speed, and low memory requirements. NTRU encryption and decryption …

Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study

P Lavie, P Herer, V Hoffstein - Bmj, 2000 - bmj.com
Objective: To assess whether sleep apnoea syndrome is an independent risk factor for
hypertension. Design: Population study. Setting: Sleep clinic in Toronto. Participants: 2677 adults, …

[BOOK][B] An Introduction to Cryptography

J Hoffstein, J Pipher, JH Silverman, J Hoffstein… - 2014 - Springer
Abstract As Julius Caesar surveys the unfolding battle from his hilltop outpost, an exhausted
and disheveled courier bursts into his presence and hands him a sheet of parchment …

Tiotropium in combination with placebo, salmeterol, or fluticasone–salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

…, R Rivington, J Road, V Hoffstein… - Annals of internal …, 2007 - acpjournals.org
Background: Treatment of moderate or severe chronic obstructive pulmonary disease (COPD)
with combinations of inhaled corticosteroids, long-acting β-agonists, and long-acting …

Predictive value of clinical features in diagnosing obstructive sleep apnea

V Hoffstein, JP Szalai - Sleep, 1993 - academic.oup.com
We examined the predictive value of history and physical examination in the diagnosis of
obstructive sleep apnea (OSA) syndrome. This was achieved by studying a set of 594 patients …

Treatment of obstructive sleep apnea with nasal continuous positive airway pressure

V Hoffstein, S Viner, S Mateika, J Conway - Am Rev Respir Dis, 1992 - atsjournals.org
Obstructive sleep apnea is a chronic disease whose treatment may require long-term nightly
use of relatively cumbersome and expensive breathing equipment that provides continuous …

Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide.

…, AS Slutsky, HG Furlott, E Hoffstein… - American journal of …, 1997 - atsjournals.org
Exhaled nitric oxide (NO) may aid in monitoring pulmonary disease. The single-breath NO
profile (subjects with nose clip) was described as a NO peak followed by a plateau (NO(PLAT)…